Abstract:Distant metastasis has become the predominant model of treatment failures in patients with locoregionally advanced nasopharyngeal carcinoma. Effort should therefore be made to stratify locoregionally advanced nasopharyngeal carcinoma patients into different groups based on the risk of metastasis to improve prognosis and tailor individualized treatments. This study aims to assess the value of primary gross tumor volume and the maximum standardized uptake value for predicting distant metastasis–free survival of patients with locoregionally advanced nasopharyngeal carcinoma. A total of 294 locoregionally advanced nasopharyngeal carcinoma patients who were identified from prospectively maintained database and underwent fluor-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging before treatment were included. The maximum standardized uptake value was recorded for the primary tumor (SUVmax-P) and neck lymph nodes (SUVmax-N). Computed tomography-derived primary gross tumor volume was measured using the summation-of-area technique. At 5 years, the distant metastasis–free survival rate was 83.7%. The cut-off of the SUVmax-P, SUVmax-N, and primary gross tumor volume for distant metastasis–free survival was 8.95, 5.75, and 31.3 mL, respectively, by receiver operating characteristic curve. In univariate analysis, only SUVmax-N (hazard ratio: 7.01; 95% confidence interval: 1.70–28.87; p < 0.01) and clinical stage (hazard ratio: 3.03; 95% confidence interval: 1.67–5.47; p = 0.007) were confirmed as independent predictors of distant metastasis–free survival. A prognostic model was derived by SUVmax-N and clinical stage: low risk (SUVmax-N < 5.75 regardless of clinical stage), medium risk (stage III and SUVmax-N ≥ 5.75), and high risk (stage IV and SUVmax-N ≥ 5.75). Multivariate analysis revealed that SUVmax-N and the prognostic model remained independent prognostic factors for distant metastasis–free survival (p = 0.023 and p < 0.001, respectively), but the clinical stage became insignificant (p = 0.133). Furthermore, the adjusted hazard ratios for the prognostic model were higher than SUVmax-N (hazard ratio = 6.27 vs 5.21, respectively). In summary, compared with SUVmax-P, SUVmax-N may be a better predictor of distant metastasis–free survival for patients with locoregionally advanced nasopharyngeal carcinoma. Combining SUVmax-N with clinical stage gives a more precise picture in predicting distant metastasis.

Pretreatment 18F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma

Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma

The role of pretreatment FDG standard uptake value in predicting for clinical outcome in locally advanced nasopharyngeal carcinoma

Reflecting on the utility of standardized uptake values on 18F-FDG PET in nasopharyngeal carcinoma

Adding Maximum Standard Uptake Value of Primary Lesion and Lymph Nodes in 18F-Fluorodeoxyglucose PET Helps Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.

Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: a prospective study with long-term follow-up.

Abstract 453: Prognostic value of18F-FDG PET/CT in nasopharyngeal carcinoma:

Prognostic Value of Pretreatment 18F-FDG PET-CT for Nasopharyngeal Carcinoma Patients.

Prognostic Value of Pre-Treatment FDG PET/CT SUVmax for Metastatic Lesions in De Novo Metastatic Nasopharyngeal Carcinoma Following Chemotherapy and Locoregional Radiotherapy

Prognostic value of primary gross tumor volume and standardized uptake value of F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma

[Serial (18)F-FDG PET-CT Imaging During Radiotherapy for Nasopharyngeal Carcinoma: a Prospective Clinical Study].

Prognostic Value of Primary Gross Tumor Volume and Standardized Uptake Value of 18F-FDG in PET/CT for Distant Metastasis in Locoregionally Advanced Nasopharyngeal Carcinoma

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients

PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma

Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein–barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma

Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT

Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein–Barr virus DNA to predict distant metastasis in nasopharyngeal …

Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.

Value of ~(18)FDG PET-CT after Radiotherapy in Nasopharyngeai Carcinoma

Combining Plasma Epstein-Barr Virus DNA and Nodal Maximal Standard Uptake Values of 18F-Fluoro-2-deoxy-d-glucose Positron Emission Tomography Improved Prognostic Stratification to Predict Distant Metastasis for Locoregionally Advanced Nasopharyngeal Carcinoma.

Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study